AlphaMaven AlphaMaven

Bain Capital’s staggering aged care valuation of Estia Health

Reported by Theweeklysource
Nov 12, 2025· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • Bain Capital is exploring exit options for Estia Health at a $2 billion valuation, roughly 2.4x the $838 million acquisition price paid in December 2023, representing substantial value creation in just two years.
  • • An Initial Public Offering (IPO) is under active consideration following Bain's successful Virgin Australia listing earlier in 2025, with UBS appointed to manage the process if it proceeds; a strategic sale remains an alternative option.
  • • Estia has expanded aggressively since acquisition, growing from 73 homes to 94 facilities through acquisitions of Vacenti Aged Care (seven Brisbane homes), Mark Moran Group (two Sydney homes), and Aurrum Aged Care (seven homes).
  • • The exit timing capitalizes on improved sector fundamentals: regulatory stability under the new Aged Care Act, enhanced government funding, and demographic tailwinds from an aging Australian population—a marked contrast to the COVID-19 and Royal Commission headwinds facing the business at acquisition.
  • • Bain has appointed Barrenjoey Capital Partners and Gresham as advisers and is conducting meetings with more than a dozen fund managers to evaluate strategic alternatives for the second-largest residential aged care operator in Australia.
Summary
Bain Capital is advancing plans to exit its investment in Estia Health, Australia's second-largest residential aged care operator, at an estimated $2 billion valuation. The US private equity firm, which acquired Estia for $838 million in December 2023, is now exploring multiple exit paths including an Initial Public Offering or a strategic sale. This represents a substantial multiple on the original investment within a two-year timeframe and signals confidence in the sector's improved fundamentals.

The timing of the potential exit reflects a markedly different operating environment than when Bain entered the market. At acquisition, the aged care sector was navigating the aftermath of the COVID-19 pandemic and the Aged Care Royal Commission. Today, regulatory clarity from the new Aged Care Act, improved government funding settings, and favorable long-term demographic trends—driven by Australia's aging population—have strengthened the investment thesis. Bain's CEO Sean Bilton had identified Estia as "a consolidator" in a fragmented market where 70% of providers operate just one or two facilities, facing rising compliance burdens under sector reforms.

Since the acquisition, Estia has executed an aggressive expansion strategy. The portfolio has grown from 73 homes at the time of purchase to 94 facilities today, achieved through three significant acquisitions: Aurrum Aged Care's seven homes in April, Mark Moran Group's Little Bay and Warrawee properties in June, and Vacenti Aged Care's seven Brisbane homes in September 2025. This consolidation reinforces the original strategic rationale.

To evaluate its options, Bain has appointed Barrenjoey Capital Partners and Gresham as financial advisers. UBS is positioned to lead the IPO process should that path be selected, drawing on recent precedent following Bain's successful Virgin Australia listing earlier in 2025. The firm is currently conducting meetings with more than a dozen fund managers as part of the strategic review process, suggesting an active market for quality aged care assets and strong buyer interest in the space.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Theweeklysource Bain Capital’s staggering aged care valuation of Estia Health